Repurposing FDA‐Approved Antiviral Drugs Against Human Metapneumovirus Fusion Protein: Integrated Docking, Molecular Dynamics, and Quantum Chemical Insights
Human metapneumovirus (HMPV) is a major respiratory pathogen lacking an approved targeted antiviral therapy. This study aimed to identify FDA‐approved antiviral drugs targeting the prefusion HMPV fusion glycoprotein using an integrated computational framework. Fourteen FDA‐approved antiviral drugs and two control c...